methylselenic acid has been researched along with carboplatin in 2 studies
| Studies (methylselenic acid) | Trials (methylselenic acid) | Recent Studies (post-2010) (methylselenic acid) | Studies (carboplatin) | Trials (carboplatin) | Recent Studies (post-2010) (carboplatin) |
|---|---|---|---|---|---|
| 144 | 1 | 68 | 12,895 | 4,001 | 5,244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, MS; Pollok, KE; Smith, ML | 1 |
| Cao, L; Cheng, WH; Fu, Y; Tzeng, TJ; Zeng, H | 1 |
2 other study(ies) available for methylselenic acid and carboplatin
| Article | Year |
|---|---|
Selenomethionine or methylseleninic acid inhibits mutagenesis of a reporter gene in mouse bone marrow.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; DNA-Binding Proteins; Genes, Reporter; Maximum Tolerated Dose; Methionine; Mice; Mice, Knockout; Mutagenesis; Organoselenium Compounds; Selenomethionine | 2010 |
Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatin.
Topics: Acetylcysteine; Antineoplastic Agents; Ataxia Telangiectasia Mutated Proteins; Carboplatin; Cell Cycle; Cell Line, Tumor; Chromones; DNA-Binding Proteins; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Morpholines; Organoselenium Compounds; Ovarian Neoplasms; Phosphorylation; Receptor, Notch3; Receptors, Notch; RNA, Messenger; Thioxanthenes | 2014 |